Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Ophthalmic Devices Market Global Briefing 2017

Ophthalmic Devices Market Global Briefing 2017

From $1,000.00

Including: Vision Care Devices, Cataract Surgery Devices , Refractive Surgery Devices, and Diagnostic and Monitoring Ophthalmic Devices
Covering: Essilor International, Alcon (Novartis), Johnson & Johnson, Abbott Medical, and Carl Zeiss AG


Clear selection
SKU: 1729. Categories: , .
Description

Ophthalmic devices are an aid in the diagnosis, monitoring, surgery and treatment of various eye related diseases such as cataract, age-related macular degeneration, glaucoma, diabetic retinopathy, retinal detachment or tear, eye infections, dry eye syndrome and others.

The Ophthalmic Devices Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the ophthalmic devices market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the ophthalmic devices market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the ophthalmic devices market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.

 

Scope

Markets Covered: Vision Care Devices, Cataract Surgery Devices , Refractive Surgery Devices, and Diagnostic and Monitoring Ophthalmic Devices

Companies Mentioned: Essilor International, Alcon (Novartis), Johnson & Johnson, Hoya Corporation, CooperVision AG, Tommy Corporation, Abbott Medical, Carl Zeiss AG, Nidek Co. Ltd., and Topcon Corporation

Geographic scope: Americas, Europe, Asia, Middle East and Africa, Oceania.

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents
Ophthalmic Devices Market Characteristics 5
Diagnostic and Monitoring Ophthalmic Devices 5
These devices 5
Vision Care Devices 5
Ophthalmic Surgery Devices 5
Ophthalmic Devices Market Historic Growth 7
Ophthalmic Devices Market Forecast Growth 8
Ophthalmic Devices Market Segmentation 9
Ophthalmic Devices Market Size, Split By Segments, 2016, $ Billion 9
Vision Care Devices 9
Cataract Surgery Devices 10
Diagnostic And Monitoring Ophthalmic Devices 10
Ophthalmic Devices Market Regional and Country Comparison 11
Global Ophthalmic Devices Market, Split By Region, 2016 11
Global Ophthalmic Devices Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 12
Global Ophthalmic Devices Market, Split By Country, 2016 14
Global Ophthalmic Devices Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 15
Ophthalmic Devices Market Competitive Landscape 18
Essilor International 19
Alcon 20
Johnson & Johnson 21
Hoya Corporation 22
Ophthalmic Devices Market Key Mergers And Acquisitions 23
Luxottica Group SpA Merger With Essilor 23
Johnson & Johnson Acquired Abbott Medical Optics 23
Hoya Corporation Acquired Performance Optics, LLC 23
Allergan Completed Acquisition of AqueSys 23
Santen Acquired InnFocus 23
Ophthalmic Devices Market Trends And Strategies 24
Emergence Of Robotic-Assisted Eye Surgery 24
Strategic Investments in R&D 24
Combination Technologies 25
Development of Drug-Dispensing Contact Lens 25
Appendix 26
NAICS Definitions of Industry Covered in this Report 26
Methodology 26
Data 26
Market Numbers 26
Competitor Market Share Data 26
Analysis 26
Verification Through Expert Interviews 26
Referencing 27
Note on Currency Conversions 27
Abbreviations 27
Currencies 27
Research Methodology 27
Research Inquiries 28
The Business Research Company 28
Executive Summary
The market segments in the ophthalmic devices as of 2016 were diagnostic and monitoring ophthalmic devices, vision care devices, and ophthalmic surgery devices (cataract surgery devices and refractive surgery devices).

The global ophthalmic devices market is expected to reach $45 billion in 2020.

The ophthalmic devices market is relatively fragmented, with few global players. The top five competitors in the market made up 68% of the total market share in 2016.

Venture capital firms are investing in major ophthalmology device manufacturing companies to take advantage of the growth in the market and the potential of new technologies within it. Venture capital firms such as Versant, SV Life Sciences, InterWest Partners, Domain Associates, Polaris, and others are investing in major competitors in the market such as Alcon, Abbott Medical Optics, and Bausch & Lomb. Venture capital (VC) backed small ophthalmic startups are developing new technologies to strengthen their position in the market. For instance, Glaukos, a US based VC-backed glaucoma treatment company is engaged in R&D of tiny stent that improves the outflow of fluid into the eye’s drainage system during glaucoma surgical procedures; Second Sight Medical is into R&D of second-generation implantable device that can restore sight to the blind; and NeuroTech Pharmaceuticals, a US based ophthalmic startup is into R&D of encapsulated cell technology used in the treatment of retinitis pigmentosa, among other diseases.
Get Customized Report
Please fill in your details. Our team will get back to you